Publications

03-28 10:07
 
Comparison of a closed system to a standard open technique for preparing tissue-engineered vascular grafts
03-28 10:07
 
Late-term results of tissue-engineered vascular grafts in humans
03-28 10:07
 
Comparison of the biological equivalence of two methods for isolating bone marrow mononuclear cells for fabricating tissue-engineered vascular grafts
03-28 10:07
 
Flexible ureterorenoscopy versus semirigid ureteroscopy for the treatment of proximal ureteral stones: a retrospective comparative analysis of 124 patients
03-28 10:07
 
Spontaneous reversal of stenosis in tissue-engineered vascular grafts
03-28 10:07
 
Angiotensin II receptor I blockade prevents stenosis of tissue engineered vascular grafts
03-28 10:07
 
Retrospective comparative study of rigid and flexible ureteroscopy for treatment of proximal ureteral stones
03-28 10:07
 
Flexible Ureteroscopy Can Be More Efficacious in the Treatment of Proximal Ureteral Stones in Select Patients
03-28 10:07
 
A prospective, multi-institutional study of flexible ureteroscopy for proximal ureteral stones smaller than 2 cm
03-28 10:07
 
Comparison of Patient Satisfaction with Treatment Outcomes between Ureteroscopy and Shock Wave Lithotripsy for Proximal Ureteral Stones
03-28 10:07
 
Biochemical and ultrastructural changes in rabbit sclera after treatment with 7-methylxanthine, theobromine, acetazolamide, or L-ornithine
03-28 10:07
 
24-h duration of the novel LABA vilanterol trifenatate in asthma patients treated with inhaled corticosteroids
03-28 10:07
 
Increased risk for postoperative periprosthetic fracture in hip fracture patients with the Exeter stem than the anatomic SP2 Lubinus stem
03-28 10:07
 
High risk of early periprosthetic fractures after primary hip arthroplasty in elderly patients using a cemented, tapered, polished stem
03-28 10:07
 
Substantially higher prevalence of postoperative peri-prosthetic fractures in octogenarians with hip fractures operated with a cemented, polished tapered stem rather than an anatomic stem
03-28 10:07
 
Cardiac disease and advanced age increase the mortality risk following surgery for periprosthetic femoral fractures
03-28 10:07
 
Janus kinase 1 inhibitor INCB054707 for patients with moderate-to-severe hidradenitis suppurativa: results from two phase II studies
03-28 10:07
 
First-in-Human Studies of MW01-6-189WH, a Brain-Penetrant, Antineuroinflammatory Small-Molecule Drug Candidate: Phase 1 Safety, Tolerability, Pharmacokinetic, and Pharmacodynamic Studies in Healthy Adult Volunteers
03-28 10:07
 
Venetoclax-Rituximab in Relapsed or Refractory Chronic Lymphocytic Leukemia
03-28 10:07
 
Venetoclax Plus Rituximab in Relapsed Chronic Lymphocytic Leukemia: 4-Year Results and Evaluation of Impact of Genomic Complexity and Gene Mutations From the MURANO Phase III Study
03-28 10:07
 
Fixed Duration of Venetoclax-Rituximab in Relapsed/Refractory Chronic Lymphocytic Leukemia Eradicates Minimal Residual Disease and Prolongs Survival: Post-Treatment Follow-Up of the MURANO Phase III Study
03-28 10:07
 
Enduring undetectable MRD and updated outcomes in relapsed/refractory CLL after fixed-duration venetoclax-rituximab
03-28 10:07
 
Bioavailability Evaluation of Venetoclax Lower-Strength Tablets and Oral Powder Formulations to Establish Interchangeability with the 100 mg Tablet
03-28 10:07
 
A technology-enhanced model of care for transitional palliative care versus attention control for adult family caregivers in rural or medically underserved areas: study protocol for a randomized controlled trial
03-28 10:07
 
Metabolic fingerprints of altered brain growth, osmoregulation and neurotransmission in a Rett syndrome model

Clinical Research News

Applying for a Paediatric investigation plan (PIP): review of the EMA guidelines
Considerations for the Use of Real-World Data and Real-World Evidence To Support Regulatory Decision-Making for Drug and Biological Products
Submission of comments on ICH E6 (R3) Guideline for Good Clinical Practice(GCP) - Step 2b 
ICH E6(R3) Good Clinical Practice guidance - Step 2 Public Consultation
The study of the new investigational drug for acute myeloid leukemia and myelodysplastic syndrome
Open Label study of entrectinib in ROS1 gene fusion-positive rare adult, paediatric and teenage/young adult cancers
Gasherbrum Bio, Inc is starting the study of GSBR-1290 drug in overweight or obese healthy adults

Próximos ensaios clínicos

Clinical Research Jobs

All jobs

Patrocinadores e Colaboradores

Condições médicas

Intervenções de drogas

3
Se inscrever